Market Research Life Sciences Market Research Pharmaceuticals Market Research Biopharmaceuticals Market Research

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-202

Best Price Guarantee Length Publisher Published Date SKU
from $3,950 119 Pages GlobalData November, 2022 GBDT17548645
Best Price Guarantee
Price from $3,950
Length 119 Pages
Publisher GlobalData
Published Date November, 2022
SKU GBDT17548645

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical), and Segment Forecast, 2022-2027

Summary

The Regenerative Medicine in Pharma market size was valued at US$29.4 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% during 2022-2027. The Regenerative Medicine in Pharma market report provides an executive-level overview of the regenerative medicine market worldwide today, with detailed forecasts of key indicators up to 2027.

This market intelligence report offers a thorough, forward-looking analysis of the Regenerative Medicine in Pharma market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

The regenerative medicine in pharma market size was valued at US$29.1 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.1% during the forecast period (2022-2027). The market is driven by the growing prevalence of chronic diseases, genetic disorders, and cancer and technological advancements in stem-cell therapies.

Scope

  • Overview of regenerative medicine in pharma market including industry trends, funding & deals, pipeline analysis, regulatory details, and product & company profile
  • Regenerative medicine in pharma market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, technology, application, and geographic segments.
  • Regenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the drug class segments.
  • Regenerative medicine in pharma market outlook: analysis as well as forecasts of revenue opportunities from the route of administration segment.
  • The competitive landscape: an examination of the positioning of leading players in regenerative medicine in pharma market.
Reasons to Buy
  • This market intelligence report offers a thorough, forward-looking analysis of the Regenerative Medicine in Pharma market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData’s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in regenerative medicine in pharma markets.
  • The report also highlights key product, therapeutic area segments.
  • With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in regenerative medicine in pharma market.


  • Executive Summary
    • Regenerative Medicine in Pharma Market Snapshot
      • Table Fig.1 Market Snapshot ($Mn)
    • Regenerative Medicine in Pharma Market- Key Findings
      • Table Fig.2 Key Segment Performance Snapshot
      • Table Key Trends Overview
  • Market Landscape
    • Market Definition
      • Table Fig.3 History of Regenerative Medicine Development in 8MM
      • Table Regenerative Medicine classification
    • Market Scope and Segmentation
      • Table Research Scope and Segmentation
    • Industry Trends
      • HEALTHCARE TRENDS
        • Table Healthcare Trends
      • REGULATORY TRENDS
        • Table Regulatory Trends
    • Opportunities in Regenerative Medicine in Pharma
      • GENE THERAPY
      • CELL THERAPY
      • TISSUE ENGINEERED PRODUCTS AND BIOMATERIALS
    • Regenerative Medicines in Clinical Trials
      • Table Fig.4 Clinical Trials, 2020
      • Table Fig.5 Clinical Trials by Therapy Areas
  • Regenerative Medicine in Pharma Value Chain
    • Value Chain Analysis
      • ARM CLASSIFICATION OF REGENERATIVE MEDICINE
        • Table Fig.6 Regenerative Medicine in Pharma Value Chain
        • Table Fig.7 Regenerative Medicine in Pharma Value Chain
        • Table Fig.8 Regenerative Medicine in Pharma Value Chain
        • Table Fig.9 Regenerative Medicine in Pharma Value Chain
  • Regulatory and Market Access
    • Table Fig.10 Stages of Clinical Development of Regenerative Medicine
    • Differences Between Conventional Therapies and Stem Cell Therapies in Clinical Trials
      • Table Fig.11 Stages of Clinical Development of Regenerative Medicine vs. Conventional Therapies
    • US
      • REGULATORY
      • MARKET ACCESS
    • Europe
    • Regulation of Regenerative Medicine in the US and Europe
      • Table Fig.12 Regenerative Medicine in Pharma Value Chain
    • Japan
    • South Korea
  • Marketed Products
    • Overview
      • Table Fig.13 Marketed Regenerative Medicine by Type and Region
      • Table Fig.14 Marketed Regenerative Medicine by Therapy Area
      • LEADING CELL-BASED IMMUNOTHERAPY TREATMENTS
        • Table Cell-Based Immunotherapy
      • LEADING GENE THERAPY TREATMENTS
        • Table Gene Therapy
      • LEADING CELL-THERAPIES TREATMENT
        • Table Cell Therapies
      • LEADING TISSUE ENGINEERED PRODUCTS TREATMENTS
        • Table Tissue-Engineered Products
  • Regenerative Medicine Pipeline Products in the 8MM
    • Table Fig.15 Pipeline Products by Type, Phase, and Therapy Area
    • Late-Stage Gene Therapy Products
      • Table Fig.16 Gene Therapy Products
    • Late-Stage Gene-Modified Cell Therapy Products
      • Table Fig.17 Gene-Modified Cell Therapy Products
    • Late-Stage Cell Therapy Products
      • Table Fig.18 Cell Therapy Products
    • Late-Stage Tissue-Engineered Treatment
      • Table Fig.19 Tissue-Engineered Treatment
  • Regenerative Medicine in Pharma Industry Analysis
    • Regenerative Medicine in Pharma Market Structure – PORTER’s Analysis
      • Table Fig.20 Global Regenerative Medicine in Pharma PORTER’s Five Force Analysis
    • Deals in Regenerative Medicine in Pharma
      • Table Deals in Regenerative Medicine in Pharma
    • Funding in Regenerative Medicine in Pharma
      • Table Funding Activity in the Regenerative medicine in Pharma Industry
  • Global Regenerative Medicine in Pharma Revenue Opportunity
    • Global Regenerative Medicine in Pharma Market
      • Table Fig.21 Global Regenerative medicine in Pharma Market - Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • Table Regenerative Medicine in Pharma Market
    • COVID-19 Pandemic
  • Regenerative Medicine in Pharma Product Outlook
    • Regenerative Medicine in Pharma – Product Dive
      • Table Fig.22 Regenerative Medicine in Pharma by Product – Market Overview ($Mn)
      • Table Fig.23 Regenerative Medicine in Pharma by Product – 2021 & 2027 (%)
      • Table Regenerative Medicine in Pharma by Product, 2020-2027 ($Mn)
      • TISSUE-ENGINEERED PRODUCTS
        • Table Fig.24 Tissue-engineered Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • GENE THERAPIES
        • Table Fig.25 Gene Therapies Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • CELL THERAPIES
        • Table Fig.26 Cell Therapies Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • OTHERS
        • Table Fig.27 Other Products Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Regenerative Medicine in Pharma Therapeutic Area Outlook
    • Regenerative Medicine in Pharma – Therapeutic Area Dive
      • Table Fig.28 Regenerative Medicine in Pharma by Therapeutic Area – Market Overview ($Mn)
      • Table Fig.29 Regenerative Medicine in Pharma by Therapeutic Area – 2021 & 2027 (%)
      • Table Regenerative Medicine in Pharma by Therapeutic Area, 2020-2027 ($Mn)
      • ONCOLOGY
        • Table Fig.30 Oncology Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • MUSCULOSKELETAL DISORDERS
        • Table Fig.31 Musculoskeletal Disorders Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • IMMUNOLOGY AND INFLAMMATION
        • Table Fig.32 Immunology and Inflammation Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • DERMATOLOGY
        • Table Fig.33 Dermatology Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
      • OTHERS
        • Table Fig.34 Other Therapeutic Areas Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Regenerative Medicine in Pharma Regional Outlook
    • Regenerative Medicine in Pharma – Regional Deep Dive
      • Table Fig.35 Regenerative Medicine in Pharma by Region– Market Overview ($Mn)
      • Table Fig.36 Regenerative Medicine in Pharma by Region Share – 2021 & 2027 (%)
      • Table Regenerative Medicine in Pharma by Region, 2020-2027 ($Mn)
      • NORTH AMERICA
        • Table Fig.37 North America Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table North America Regenerative Medicine in Pharma by Country, 2020-2027 ($Mn)
      • EUROPE
        • Table Fig.38 Europe Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table Europe Regenerative Medicine in Pharma by Country, 2020-2027 ($Mn)
      • ASIA-PACIFIC
        • Table Fig.39 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
        • Table Asia-Pacific Regenerative Medicine in Pharma by Country, 2020-2027 ($Mn)
      • ROW
        • Table Fig.40 ROW Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
  • Trends, Drivers, and Challenges
    • Regenerative Medicine in Pharma – Market Trends
      • CONSTANT INNOVATION IN CELL ENGINEERING TECHNIQUES:
      • INCREASING APPLICATION OF GENE THERAPY:
      • FAST TRACK APPROVALS AND MULTIPLE DRUGS IN LAST STAGES OF PIPELINE
      • THE MOMENTUM CREATED BY ALLOGENIC THERAPEUTICS CONTINUES TO DRIVE MARKET:
      • INCREASING APPLICATIONS OF 3D PRINTING IN REGENERATIVE MEDICINE:
    • Regenerative Medicine in Pharma – Market Drivers
      • GROWING PREVALENCE OF CHRONIC DISEASES, GENETIC DISORDERS, AND CANCER
      • TECHNOLOGICAL ADVANCEMENTS IN STEM-CELL THERAPIES
      • INCREASED INVESTMENT BY KEY PLAYERS IN R&D OF THE REGENERATIVE MEDICINES
    • Regenerative Medicine in Pharma – Market Challenges
      • GENE THERAPY
      • CELL THERAPY
      • TISSUE-ENGINEERED PRODUCTS AND BIOMATERIALS
  • Regenerative Medicine in Pharma Market Vendor Snapshot
    • COMPANY SNAPSHOT: NOVARTIS AG
    • COMPANY SNAPSHOT: GILEAD
    • COMPANY SNAPSHOT: AMGEN
    • COMPANY SNAPSHOT: BRISTOL-MYERS SQUIBB COMPANY
    • COMPANY SNAPSHOT: BLUE BIRD BIO
    • COMPANY SNAPSHOT: JOHNSON & JOHNSON
    • COMPANY SNAPSHOT: BIOMARIN PHARMACEUTICAL INC
    • COMPANY SNAPSHOT: PTC THERAPEUTICS
    • COMPANY SNAPSHOT: ORCHARD THERAPEUTICS
    • COMPANY SNAPSHOT: VERICEL CORPORATION
  • Appendix
    • Methodology
    • About US

$3,950
$5,950
$7,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings